Cooperative AgreementPostedDiscretionary

Maternal and Pediatric Precision in Therapeutics (MPRINT) Knowledge and Research Coordination Center

National Institutes of Health
RFA-HD-26-009
Application Deadline
Days Remaining
Until deadline
Award Ceiling
Total Program Funding
$3,625,000

Grant Opportunity Analysis

The National Institutes of Health (NIH) is announcing a funding opportunity for the establishment of the Maternal and Pediatric Precision in Therapeutics (MPRINT) Knowledge and Research Coordination Center through a cooperative agreement. This initiative aims to enhance drug development and regulatory science for maternal and pediatric therapeutics by creating a pharmacology knowledgebase, utilizing real-world clinical data, and fostering innovative clinical trials, while also training the future workforce in this critical area. The total estimated funding for this program is $3,625,000, with one award anticipated, and interested parties can reach out to Lesly-Anne Samedy-Bates at lesly-anne.samedy-bates@nih.gov or by phone at 301-219-7492 for further information. The estimated synopsis post date is November 21, 2025, with a closing date for applications expected by March 2, 2026, and project commencement anticipated on December 1, 2026.

Eligible Applicants

Others
Additional Eligibility Information

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Grant Documents

0 Files
No documents available for this grant.

Related Grant Opportunities

Project Timeline

postedOriginal Opportunity PostedSep 15, 2025

Funding Details

Est. Total Program Funding
$3,625,000
Expected Awards
1
No cost sharing required

Agency & Classification

Agency
National Institutes of Health(HHS-NIH11)
Funding Category
Health
Funding Instrument
Cooperative Agreement

Grantor Contact

Name
Lesly-Anne Samedy-Bates, Pharm.D., Ph.D., M.S.

CFDA Numbers

93.865

Official Sources